Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

GEVO vs VERO vs AMTX vs REX vs GPRE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
GEVO
Gevo, Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$493M
5Y Perf.+57.4%
VERO
Venus Concept Inc.

Medical - Devices

HealthcareNASDAQ • CA
Market Cap$499K
5Y Perf.-99.9%
AMTX
Aemetis, Inc.

Oil & Gas Refining & Marketing

EnergyNASDAQ • US
Market Cap$213M
5Y Perf.+290.0%
REX
REX American Resources Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$1.60B
5Y Perf.+398.3%
GPRE
Green Plains Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$1.15B
5Y Perf.+92.5%

GEVO vs VERO vs AMTX vs REX vs GPRE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
GEVO logoGEVO
VERO logoVERO
AMTX logoAMTX
REX logoREX
GPRE logoGPRE
IndustryChemicals - SpecialtyMedical - DevicesOil & Gas Refining & MarketingChemicals - SpecialtyChemicals - Specialty
Market Cap$493M$499K$213M$1.60B$1.15B
Revenue (TTM)$174M$59M$209M$651M$1.94B
Net Income (TTM)$-11M$-55M$-74M$50M$-15M
Gross Margin23.4%64.4%3.4%12.7%1.8%
Operating Margin-4.6%-59.0%-13.4%8.6%1.2%
Forward P/E62.8x46.6x
Total Debt$168M$43M$318M$21M$508M
Cash & Equiv.$1M$4M$5M$196M$182M

GEVO vs VERO vs AMTX vs REX vs GPRELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

GEVO
VERO
AMTX
REX
GPRE
StockMay 20May 26Return
Gevo, Inc. (GEVO)100157.4+57.4%
Venus Concept Inc. (VERO)1000.1-99.9%
Aemetis, Inc. (AMTX)100390.0+290.0%
REX American Resour… (REX)100498.3+398.3%
Green Plains Inc. (GPRE)100192.5+92.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: GEVO vs VERO vs AMTX vs REX vs GPRE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: REX leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Green Plains Inc. is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. GEVO also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
GEVO
Gevo, Inc.
The Growth Play

GEVO ranks third and is worth considering specifically for growth exposure.

  • Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
  • 8.5% revenue growth vs REX's -22.9%
Best for: growth exposure
VERO
Venus Concept Inc.
The Healthcare Pick

VERO lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
AMTX
Aemetis, Inc.
The Energy Pick

Among these 5 stocks, AMTX doesn't own a clear edge in any measured category.

Best for: energy exposure
REX
REX American Resources Corporation
The Income Pick

REX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • beta 0.36
  • 464.7% 10Y total return vs GPRE's 21.3%
  • Lower volatility, beta 0.36, Low D/E 3.3%, current ratio 8.64x
  • Beta 0.36, current ratio 8.64x
Best for: income & stability and long-term compounding
GPRE
Green Plains Inc.
The Value Play

GPRE is the #2 pick in this set and the best alternative if value and momentum is your priority.

  • Lower P/E (46.6x vs 62.8x)
  • +336.6% vs VERO's -88.5%
Best for: value and momentum
See the full category breakdown
CategoryWinnerWhy
GrowthGEVO logoGEVO8.5% revenue growth vs REX's -22.9%
ValueGPRE logoGPRELower P/E (46.6x vs 62.8x)
Quality / MarginsREX logoREX7.7% margin vs VERO's -92.8%
Stability / SafetyREX logoREXBeta 0.36 vs GEVO's 1.64, lower leverage
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)GPRE logoGPRE+336.6% vs VERO's -88.5%
Efficiency (ROA)REX logoREX6.7% ROA vs VERO's -88.6%, ROIC 11.4% vs -39.8%

GEVO vs VERO vs AMTX vs REX vs GPRE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

GEVOGevo, Inc.
FY 2025
Ethanol
95.6%$105M
Hydrocarbon
4.4%$5M
VEROVenus Concept Inc.
FY 2024
System
58.6%$38M
Leases
20.5%$13M
Product
16.1%$10M
Service
4.7%$3M
AMTXAemetis, Inc.
FY 2025
Ethanol Sales
79.4%$116M
Wet Distiller's Grains Sales
20.6%$30M
REXREX American Resources Corporation
FY 2024
Other Member
100.0%$329,000
GPREGreen Plains Inc.
FY 2025
Products And Services Other
101.2%$94M
Intersegment Revenues
-1.2%$-1,119,000

GEVO vs VERO vs AMTX vs REX vs GPRE — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLREXLAGGINGGPRE

Income & Cash Flow (Last 12 Months)

Evenly matched — REX and GPRE each lead in 2 of 6 comparable metrics.

GPRE is the larger business by revenue, generating $1.9B annually — 32.9x VERO's $59M. REX is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to VERO's -92.8%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricGEVO logoGEVOGevo, Inc.VERO logoVEROVenus Concept Inc.AMTX logoAMTXAemetis, Inc.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.
RevenueTrailing 12 months$174M$59M$209M$651M$1.9B
EBITDAEarnings before interest/tax$18M-$31M-$21M$67M$122M
Net IncomeAfter-tax profit-$11M-$55M-$74M$50M-$15M
Free Cash FlowCash after capex-$35M-$21M-$38M$18M$90M
Gross MarginGross profit ÷ Revenue+23.4%+64.4%+3.4%+12.7%+1.8%
Operating MarginEBIT ÷ Revenue-4.6%-59.0%-13.4%+8.6%+1.2%
Net MarginNet income ÷ Revenue-6.6%-92.8%-35.4%+7.7%-0.8%
FCF MarginFCF ÷ Revenue-19.9%-35.2%-18.2%+2.7%+4.7%
Rev. Growth (YoY)Latest quarter vs prior year+47.5%-8.2%+27.4%+0.4%-25.9%
EPS Growth (YoY)Latest quarter vs prior year+3.8%-8.5%+29.8%+2.9%+134.2%
Evenly matched — REX and GPRE each lead in 2 of 6 comparable metrics.

Valuation Metrics

VERO leads this category, winning 2 of 5 comparable metrics.

On an enterprise value basis, REX's 16.6x EV/EBITDA is more attractive than GPRE's 103.8x.

MetricGEVO logoGEVOGevo, Inc.VERO logoVEROVenus Concept Inc.AMTX logoAMTXAemetis, Inc.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.
Market CapShares × price$493M$498,989$213M$1.6B$1.1B
Enterprise ValueMkt cap + debt − cash$659M$39M$526M$1.4B$1.5B
Trailing P/EPrice ÷ TTM EPS-14.50x-0.00x-2.44x29.50x-9.14x
Forward P/EPrice ÷ next-FY EPS est.62.81x46.62x
PEG RatioP/E ÷ EPS growth rate0.55x
EV / EBITDAEnterprise value multiple102.12x16.60x103.82x
Price / SalesMarket cap ÷ Revenue3.07x0.01x1.02x2.50x0.55x
Price / BookPrice ÷ Book value/share1.01x0.07x2.67x1.44x
Price / FCFMarket cap ÷ FCF17.84x
VERO leads this category, winning 2 of 5 comparable metrics.

Profitability & Efficiency

REX leads this category, winning 8 of 9 comparable metrics.

REX delivers a 7.7% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-17 for VERO. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to VERO's 15.16x. On the Piotroski fundamental quality scale (0–9), VERO scores 5/9 vs GPRE's 4/9, reflecting solid financial health.

MetricGEVO logoGEVOGevo, Inc.VERO logoVEROVenus Concept Inc.AMTX logoAMTXAemetis, Inc.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.
ROE (TTM)Return on equity-2.4%-17.4%+7.7%-2.0%
ROA (TTM)Return on assets-1.7%-88.6%-29.3%+6.7%-1.0%
ROICReturn on invested capital-2.8%-39.8%-70.3%+11.4%-5.2%
ROCEReturn on capital employed-3.1%-54.2%-19.0%+10.1%-6.2%
Piotroski ScoreFundamental quality 0–945454
Debt / EquityFinancial leverage0.36x15.16x0.03x0.66x
Net DebtTotal debt minus cash$166M$39M$313M-$175M$326M
Cash & Equiv.Liquid assets$1M$4M$5M$196M$182M
Total DebtShort + long-term debt$168M$43M$318M$21M$508M
Interest CoverageEBIT ÷ Interest expense-0.04x-9.69x-0.27x-0.08x
REX leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

REX leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in REX five years ago would be worth $34,996 today (with dividends reinvested), compared to $9 for VERO. Over the past 12 months, GPRE leads with a +336.6% total return vs VERO's -88.5%. The 3-year compound annual growth rate (CAGR) favors REX at 50.8% vs VERO's -79.4% — a key indicator of consistent wealth creation.

MetricGEVO logoGEVOGevo, Inc.VERO logoVEROVenus Concept Inc.AMTX logoAMTXAemetis, Inc.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.
YTD ReturnYear-to-date-1.5%-82.3%+96.2%+50.2%+60.1%
1-Year ReturnPast 12 months+88.0%-88.5%+140.0%+147.6%+336.6%
3-Year ReturnCumulative with dividends+65.0%-99.1%+37.4%+243.1%-46.8%
5-Year ReturnCumulative with dividends-65.2%-99.9%-76.1%+250.0%-48.5%
10-Year ReturnCumulative with dividends-98.6%-100.0%+31.1%+464.7%+21.3%
CAGR (3Y)Annualised 3-year return+18.2%-79.4%+11.2%+50.8%-19.0%
REX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

REX leads this category, winning 2 of 2 comparable metrics.

REX is the less volatile stock with a 0.36 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. REX currently trades 91.2% from its 52-week high vs VERO's 2.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricGEVO logoGEVOGevo, Inc.VERO logoVEROVenus Concept Inc.AMTX logoAMTXAemetis, Inc.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.
Beta (5Y)Sensitivity to S&P 5001.64x1.43x1.46x0.36x1.22x
52-Week HighHighest price in past year$2.97$12.93$3.80$53.36$18.94
52-Week LowLowest price in past year$1.01$0.26$1.22$19.44$3.39
% of 52W HighCurrent price vs 52-week peak+68.4%+2.1%+82.1%+91.2%+86.9%
RSI (14)Momentum oscillator 0–10053.542.958.259.154.3
Avg Volume (50D)Average daily shares traded4.5M9K1.8M204K1.5M
REX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: GEVO as "Buy", AMTX as "Buy", REX as "Buy", GPRE as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -43.9% for AMTX (target: $2).

MetricGEVO logoGEVOGevo, Inc.VERO logoVEROVenus Concept Inc.AMTX logoAMTXAemetis, Inc.REX logoREXREX American Reso…GPRE logoGPREGreen Plains Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$3.50$1.75$60.00$13.80
# AnalystsCovering analysts147320
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+0.9%+2.6%
Insufficient data to determine a leader in this category.
Key Takeaway

REX leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). VERO leads in 1 (Valuation Metrics). 1 tied.

Best OverallREX American Resources Corp… (REX)Leads 3 of 6 categories
Loading custom metrics...

GEVO vs VERO vs AMTX vs REX vs GPRE: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is GEVO or VERO or AMTX or REX or GPRE a better buy right now?

For growth investors, Gevo, Inc.

(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -22. 9% for REX American Resources Corporation (REX). REX American Resources Corporation (REX) offers the better valuation at 29. 5x trailing P/E (62. 8x forward), making it the more compelling value choice. Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — GEVO or VERO or AMTX or REX or GPRE?

On forward P/E, Green Plains Inc.

is actually cheaper at 46. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — GEVO or VERO or AMTX or REX or GPRE?

Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.

0%, compared to -99. 9% for Venus Concept Inc. (VERO). Over 10 years, the gap is even starker: REX returned +464. 7% versus VERO's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — GEVO or VERO or AMTX or REX or GPRE?

By beta (market sensitivity over 5 years), REX American Resources Corporation (REX) is the lower-risk stock at 0.

36β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately 352% more volatile than REX relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 15% for Venus Concept Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — GEVO or VERO or AMTX or REX or GPRE?

By revenue growth (latest reported year), Gevo, Inc.

(GEVO) is pulling ahead at 849. 3% versus -22. 9% for REX American Resources Corporation (REX). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -869. 0% for Venus Concept Inc.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — GEVO or VERO or AMTX or REX or GPRE?

REX American Resources Corporation (REX) is the more profitable company, earning 9.

1% net margin versus -72. 5% for Venus Concept Inc. — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -41. 9% for VERO. At the gross margin level — before operating expenses — VERO leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is GEVO or VERO or AMTX or REX or GPRE more undervalued right now?

On forward earnings alone, Green Plains Inc.

(GPRE) trades at 46. 6x forward P/E versus 62. 8x for REX American Resources Corporation — 16. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEVO: 72. 4% to $3. 50.

08

Which pays a better dividend — GEVO or VERO or AMTX or REX or GPRE?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is GEVO or VERO or AMTX or REX or GPRE better for a retirement portfolio?

For long-horizon retirement investors, REX American Resources Corporation (REX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

36), +464. 7% 10Y return). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (REX: +464. 7%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between GEVO and VERO and AMTX and REX and GPRE?

These companies operate in different sectors (GEVO (Basic Materials) and VERO (Healthcare) and AMTX (Energy) and REX (Basic Materials) and GPRE (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: GEVO is a small-cap high-growth stock; VERO is a small-cap quality compounder stock; AMTX is a small-cap quality compounder stock; REX is a small-cap quality compounder stock; GPRE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

GEVO

High-Growth Disruptor

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 23%
  • Gross Margin > 14%
Run This Screen
Stocks Like

VERO

Quality Business

  • Sector: Healthcare
  • Market Cap > $20B
  • Gross Margin > 38%
Run This Screen
Stocks Like

AMTX

High-Growth Disruptor

  • Sector: Energy
  • Market Cap > $100B
  • Revenue Growth > 13%
Run This Screen
Stocks Like

REX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

GPRE

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform GEVO and VERO and AMTX and REX and GPRE on the metrics below

Revenue Growth>
%
(GEVO: 47.5% · VERO: -8.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.